This inventor holds 2 USPTO granted patents. Top assignees: Societe De Conseils De Recherches Et D'applications Scientifiques (s.c.r.a.s.), Warner-Lambert Company. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Jacques Hamon: Innovator in Medical Treatments
Introduction
Jacques Hamon is a notable inventor based in Orsay, France. He has made significant contributions to the field of medicine, particularly in the development of treatments for various health conditions. With a total of 2 patents, his work has the potential to impact many lives.
Latest Patents
Hamon's latest patents include a method for preventing and treating arthritis, osteo-traumatic pain, and neuralgias using trimebutine. This invention focuses on the use of trimebutine, a compound known for its therapeutic properties, in the preparation of a medicament aimed at alleviating these painful conditions. Another significant patent involves phencyclidine derivatives, which are novel compounds with selective affinity for low-affinity receptors. This invention details methods for preparing these derivatives, their pharmaceutical compositions, and their potential use as protective agents for nervous system cells.
Career Highlights
Throughout his career, Jacques Hamon has worked with reputable organizations, including Société De Conseils De Recherches Et D'applications Scientifiques (SCRAS) and Warner-Lambert Company. His experience in these companies has contributed to his expertise in pharmaceutical innovations.
Collaborations
Hamon has collaborated with notable individuals in his field, including François Roman and Agnès Grouhel. These partnerships have likely enriched his research and development efforts.
Conclusion
Jacques Hamon is a distinguished inventor whose work in medical treatments showcases his dedication to improving health outcomes. His innovative patents reflect a commitment to addressing significant health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile